{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T13:44:43Z","timestamp":1790603083013,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100020320","name":"institut de recherche en sant\u00e9 publique","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100020320","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100010102","name":"institut national de pr\u00e9vention et d'\u00e9ducation pour la sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Preventive interventions for dementia are urgently needed and must be tested in randomised controlled trials (RCTs). Selection (volunteer) bias may limit efficacy, particularly in trials testing multidomain interventions and may also be indicative of disparities in intervention uptake in real-world settings. We identified factors associated with participation and adherence in a 3-year RCT of multidomain lifestyle intervention and\/or omega-3 supplementation for prevention of cognitive decline and explored reasons for (non-) participation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Ancillary study during recruitment and follow-up of the 3-year Multidomain Alzheimer Preventive Trial (MAPT) conducted in in 13 memory centres in France and Monaco, involving 1630 community-dwelling dementia-free individuals aged \u2265 70 who were pre-screened for MAPT (1270 participated in MAPT; 360 declined to participate).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Response rates were 76% amongst MAPT participants and 53% amongst non-participants. Older individuals (odds ratio 0.94 [95% confidence interval 0.91\u20130.98] and those with higher anxiety (0.61 [0.47\u20130.79]) were less likely to participate in the trial. Those with higher income (4.42 [2.12\u20139.19]) and family history (1.60 [1.10\u20132.32]) or greater fear (1.73 [1.30\u20132.29]) of dementia were more likely to participate, as were those recruited via an intermediary (e.g. pension funds, local Alzheimer\u2019s associations, University of the 3rd Age, sports clubs) (2.15 [1.45\u20133.20]). MAPT participants living in larger towns (0.71 [0.55\u20130.92]) and with higher depressive symptoms (0.94 [0.90\u20130.99]) were less likely to adhere to the interventions. Greater perceived social support (1.21 [1.03\u20131.43]) and cognitive function (1.37 [1.13\u20131.67]) predicted better adherence. Descriptively, the most frequent reasons for accepting and refusing to participate were, respectively, altruism and logistical constraints, but underlying motivations mainly related to (lack of) perceived benefits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Disparities in uptake of health interventions persist in older age. Those most at risk of dementia may not participate in or adhere to preventive interventions. Barriers to implementing lifestyle changes for dementia prevention include lack of knowledge about potential benefits, lack of support networks, and (perceived) financial costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00672685\">NCT00672685<\/jats:ext-link>\n                      (ClinicalTrials.gov)\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-021-00904-6","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T09:10:08Z","timestamp":1632474608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1671-824X","authenticated-orcid":false,"given":"Nicola","family":"Coley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Coniasse-Brioude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Igier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the ACCEPT study group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Coley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Gardette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Igier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine Coniasse","family":"Brioude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa Munoz","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Pierre","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Arandjelovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Oustric","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Subra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"key":"904_CR1","doi-asserted-by":"publisher","unstructured":"G. B. D. Dementia Collaborators GBDD. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88\u2013106. https:\/\/doi.org\/10.1016\/S1474-4422(18)30403-4.","DOI":"10.1016\/S1474-4422(18)30403-4"},{"issue":"10248","key":"904_CR2","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413\u201346. https:\/\/doi.org\/10.1016\/S0140-6736(20)30367-6.","journal-title":"Lancet"},{"issue":"9","key":"904_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/S1474-4422(15)00153-2","volume":"14","author":"S Andrieu","year":"2015","unstructured":"Andrieu S, Coley N, Lovestone S, Aisen PS, Vellas B. Prevention of sporadic Alzheimer\u2019s disease: lessons learned from clinical trials and future directions. Lancet Neurol. 2015;14(9):926\u201344. https:\/\/doi.org\/10.1016\/S1474-4422(15)00153-2.","journal-title":"Lancet Neurol"},{"issue":"1","key":"904_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1474-4422(17)30431-3","volume":"17","author":"M Kivipelto","year":"2018","unstructured":"Kivipelto M, Mangialasche F, Ngandu T, World Wide Fingers N. World Wide Fingers will advance dementia prevention. Lancet Neurol. 2018;17(1):27.","journal-title":"Lancet Neurol"},{"issue":"5","key":"904_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S1474-4422(17)30040-6","volume":"16","author":"S Andrieu","year":"2017","unstructured":"Andrieu S, Guyonnet S, Coley N, Cantet C, Bonnefoy M, Bordes S, et al. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial. Lancet Neurol. 2017;16(5):377\u201389. https:\/\/doi.org\/10.1016\/S1474-4422(17)30040-6.","journal-title":"Lancet Neurol"},{"issue":"10046","key":"904_CR6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/S0140-6736(16)30950-3","volume":"388","author":"EP Moll van Charante","year":"2016","unstructured":"Moll van Charante EP, Richard E, Eurelings LS, et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. Lancet. 2016;388(10046):797\u2013805. https:\/\/doi.org\/10.1016\/S0140-6736(16)30950-3.","journal-title":"Lancet"},{"issue":"9984","key":"904_CR7","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Lev\u00e4lahti E, Ahtiluoto S, Antikainen R, et al. A 2\u2009year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(15)60461-5.","journal-title":"Lancet"},{"issue":"8 Suppl","key":"904_CR8","doi-asserted-by":"publisher","first-page":"85S","DOI":"10.1177\/0898264313497795","volume":"25","author":"JJ Prindle","year":"2013","unstructured":"Prindle JJ, McArdle JJ. How representative is the ACTIVE sample? A statistical comparison of the ACTIVE sample and the HRS sample. J Aging Health. 2013;25(8 Suppl):85S\u2013102S. https:\/\/doi.org\/10.1177\/0898264313497795.","journal-title":"J Aging Health"},{"issue":"7","key":"904_CR9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1111\/jgs.14834","volume":"65","author":"CRL Beishuizen","year":"2017","unstructured":"Beishuizen CRL, Coley N. Moll van Charante EP, van Gool WA, Richard E, Andrieu S. Determinants of dropout and nonadherence in a dementia prevention randomized controlled trial: the prevention of dementia by intensive vascular care trial. J Am Geriatr Soc. 2017;65(7):1505\u201313. https:\/\/doi.org\/10.1111\/jgs.14834.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"904_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.jalz.2019.03.005","volume":"15","author":"N Coley","year":"2019","unstructured":"Coley N, Ngandu T, Lehtisalo J, Soininen H, Vellas B, Richard E, et al. Adherence to multidomain interventions for dementia prevention: Data from the FINGER and MAPT trials. Alzheimers Dement. 2019;15(6):729\u201341. https:\/\/doi.org\/10.1016\/j.jalz.2019.03.005.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"904_CR11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1186\/1745-6215-15-508","volume":"15","author":"HH Dodge","year":"2014","unstructured":"Dodge HH, Katsumata Y, Zhu J, Mattek N, Bowman M, Gregor M, et al. Characteristics associated with willingness to participate in a randomized controlled behavioral clinical trial using home-based personal computers and a webcam. Trials. 2014;15(1):508. https:\/\/doi.org\/10.1186\/1745-6215-15-508.","journal-title":"Trials"},{"issue":"6","key":"904_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.cct.2006.06.007","volume":"27","author":"AL Fitzpatrick","year":"2006","unstructured":"Fitzpatrick AL, Fried LP, Williamson J, Crowley P, Posey D, Kwong L, et al. Recruitment of the elderly into a pharmacologic prevention trial: the Ginkgo Evaluation of Memory Study experience. Contemp Clin Trials. 2006;27(6):541\u201353. https:\/\/doi.org\/10.1016\/j.cct.2006.06.007.","journal-title":"Contemp Clin Trials"},{"issue":"9","key":"904_CR13","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.3390\/ijerph110909345","volume":"11","author":"T Ngandu","year":"2014","unstructured":"Ngandu T, Lehtisalo J, Levalahti E, et al. Recruitment and baseline characteristics of participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)-a randomized controlled lifestyle trial. Int J Environ Res Public Health. 2014;11(9):9345\u201360. https:\/\/doi.org\/10.3390\/ijerph110909345.","journal-title":"Int J Environ Res Public Health"},{"key":"904_CR14","doi-asserted-by":"crossref","unstructured":"Rosenstock IM. The Health Belief Model and Preventive Health Behavior. Health Educ Monographs. 1974;2(35-86).","DOI":"10.1177\/109019817400200405"},{"issue":"4","key":"904_CR15","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s12603-012-0045-9","volume":"16","author":"S Andrieu","year":"2012","unstructured":"Andrieu S, Coley N, Gardette V, Subra J, Oustric S, Fournier T, et al. Representations and practices of prevention in elderly populations: investigating acceptance to participate in and adhesion to an intervention study for the prevention of Alzheimer\u2019s disease (ACCEPT study)--the need for a multidisciplinary approach. J Nutr Health Aging. 2012;16(4):352\u20134. https:\/\/doi.org\/10.1007\/s12603-012-0045-9.","journal-title":"J Nutr Health Aging"},{"key":"904_CR16","doi-asserted-by":"crossref","unstructured":"Prom-Wormley EC, Clifford JS, Bourdon JL, et al. Developing community-based health education strategies with family history: assessing the association between community resident family history and interest in health education. Soc Sci Med. 2019:112160.","DOI":"10.1016\/j.socscimed.2019.02.011"},{"issue":"4","key":"904_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1006\/pmed.2000.0725","volume":"31","author":"J Wardle","year":"2000","unstructured":"Wardle J, Sutton S, Williamson S, Taylor T, McCaffery K, Cuzick J, et al. Psychosocial influences on older adults\u2019 interest in participating in bowel cancer screening. Prev Med. 2000;31(4):323\u201334. https:\/\/doi.org\/10.1006\/pmed.2000.0725.","journal-title":"Prev Med"},{"issue":"9","key":"904_CR18","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1001\/archinte.167.9.905","volume":"167","author":"EL Ding","year":"2007","unstructured":"Ding EL, Powe NR, Manson JE, Sherber NS, Braunstein JB. Sex differences in perceived risks, distrust, and willingness to participate in clinical trials: a randomized study of cardiovascular prevention trials. Arch Intern Med. 2007;167(9):905\u201312. https:\/\/doi.org\/10.1001\/archinte.167.9.905.","journal-title":"Arch Intern Med"},{"issue":"2","key":"904_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1071\/HE14111","volume":"26","author":"BJ Smith","year":"2015","unstructured":"Smith BJ, Ali S, Quach H. The motivation and actions of Australians concerning brain health and dementia risk reduction. Health Promot J Austr. 2015;26(2):115\u201321. https:\/\/doi.org\/10.1071\/HE14111.","journal-title":"Health Promot J Austr"},{"key":"904_CR20","unstructured":"Coley N, Rosenberg A, van Middelaar T, et al. Older adults\u2019 reasons for participating in an eHealth prevention trial: a cross-country, mixed-methods comparison. J Am Med Dir Assoc. 2018."},{"issue":"1","key":"904_CR21","doi-asserted-by":"publisher","first-page":"e0145074","DOI":"10.1371\/journal.pone.0145074","volume":"11","author":"S Kelly","year":"2016","unstructured":"Kelly S, Martin S, Kuhn I, Cowan A, Brayne C, Lafortune L. Barriers and facilitators to the uptake and maintenance of healthy behaviours by people at mid-life: a rapid systematic review. PLoS One. 2016;11(1):e0145074. https:\/\/doi.org\/10.1371\/journal.pone.0145074.","journal-title":"PLoS One"},{"issue":"6","key":"904_CR22","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S1474-4422(04)00767-7","volume":"3","author":"L Fratiglioni","year":"2004","unstructured":"Fratiglioni L, Paillard-Borg S, Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol. 2004;3(6):343\u201353. https:\/\/doi.org\/10.1016\/S1474-4422(04)00767-7.","journal-title":"Lancet Neurol"},{"issue":"4","key":"904_CR23","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1093\/ageing\/afh109","volume":"33","author":"EP Tolmie","year":"2004","unstructured":"Tolmie EP, Mungall MM, Louden G, Lindsay GM, Gaw A. Understanding why older people participate in clinical trials: the experience of the Scottish PROSPER participants. Age Ageing. 2004;33(4):374\u20138. https:\/\/doi.org\/10.1093\/ageing\/afh109.","journal-title":"Age Ageing"},{"issue":"7191","key":"904_CR24","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1136\/bmj.318.7191.1114","volume":"318","author":"AJ Welton","year":"1999","unstructured":"Welton AJ, Vickers MR, Cooper JA, Meade TW, Marteau TM. Is recruitment more difficult with a placebo arm in randomised controlled trials? A quasirandomised, interview based study. BMJ. 1999;318(7191):1114\u20137. https:\/\/doi.org\/10.1136\/bmj.318.7191.1114.","journal-title":"BMJ"},{"issue":"8","key":"904_CR25","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1080\/13607863.2020.1786801","volume":"25","author":"LL Parial","year":"2021","unstructured":"Parial LL, Lam SC, Ho JYS, Suen LKP, Leung AYM. Public knowledge of the influence of modifiable cardiovascular risk factors on dementia: a systematic literature review and meta-analysis. Aging Mental Health. 2021;25(8):1395\u2013409. https:\/\/doi.org\/10.1080\/13607863.2020.1786801.","journal-title":"Aging Mental Health"},{"issue":"1","key":"904_CR26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.14283\/jpad.2017.27","volume":"5","author":"KJ Anstey","year":"2018","unstructured":"Anstey KJ, Peters R. Oversimplification of dementia risk reduction messaging is a threat to knowledge translation in dementia prevention research. J Prev Alzheimers Dis. 2018;5(1):2\u20134. https:\/\/doi.org\/10.14283\/jpad.2017.27.","journal-title":"J Prev Alzheimers Dis"},{"issue":"5 Suppl","key":"904_CR27","doi-asserted-by":"publisher","first-page":"S381","DOI":"10.1016\/j.jalz.2013.07.001","volume":"10","author":"JS Roberts","year":"2014","unstructured":"Roberts JS, McLaughlin SJ, Connell CM. Public beliefs and knowledge about risk and protective factors for Alzheimer\u2019s disease. Alzheimers Dement. 2014;10(5 Suppl):S381\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2013.07.001.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"904_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1023\/A:1005153909429","volume":"25","author":"M Boles","year":"2000","unstructured":"Boles M, Getchell WS, Feldman G, McBride R, Hart RG. Primary prevention studies and the healthy elderly: evaluating barriers to recruitment. J Community Health. 2000;25(4):279\u201392. https:\/\/doi.org\/10.1023\/A:1005153909429.","journal-title":"J Community Health"},{"issue":"2","key":"904_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1123\/japa.9.2.91","volume":"9","author":"KA Martin","year":"2001","unstructured":"Martin KA, Sinden AR. Who will stay and who will go? A review of older adults\u2019 adherence to randomized controlled trials of exercise. J Aging Phys Act. 2001;9(2):91\u2013114. https:\/\/doi.org\/10.1123\/japa.9.2.91.","journal-title":"J Aging Phys Act"},{"issue":"1","key":"904_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.maturitas.2009.07.011","volume":"64","author":"P Clarke","year":"2009","unstructured":"Clarke P, Nieuwenhuijsen ER. Environments for healthy ageing: a critical review. Maturitas. 2009;64(1):14\u20139. https:\/\/doi.org\/10.1016\/j.maturitas.2009.07.011.","journal-title":"Maturitas"},{"issue":"10","key":"904_CR31","doi-asserted-by":"publisher","first-page":"e76564","DOI":"10.1371\/journal.pone.0076564","volume":"8","author":"P Kinderman","year":"2013","unstructured":"Kinderman P, Schwannauer M, Pontin E, Tai S. Psychological processes mediate the impact of familial risk, social circumstances and life events on mental health. PLoS One. 2013;8(10):e76564. https:\/\/doi.org\/10.1371\/journal.pone.0076564.","journal-title":"PLoS One"},{"key":"904_CR32","doi-asserted-by":"crossref","DOI":"10.4135\/9781446251058","volume-title":"Key concepts in social gerontology","author":"J Phillips","year":"2010","unstructured":"Phillips J, Ajrouch K, Hillcoat-Nalletamby S. Key concepts in social gerontology. Los Angeles: Sage; 2010."},{"key":"904_CR33","unstructured":"Risk reduction of cognitive decline and dementia. WHO guidelines. Geneva: World Health Organization; 2019. ISBN-13: 978-92-4-155054-3."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00904-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00904-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00904-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T21:32:21Z","timestamp":1673299941000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00904-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["904"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00904-6","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"assertion":[{"value":"18 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The MAPT trial protocol, including the ACCEPT sub-study, was approved by the Toulouse ethics committee (CPP SOOM II) and the French Health Authority, and trial participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SA reports grants from EU programs, Fondation de l\u2019Avenir, and the AMPA and France Alzheimer Associations; personal fees from Nestl\u00e9, Nestec SA, Sanofi, and MSD; and non-financial support from Biogen, Pfizer, and Icon outside the submitted work. The other authors have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}